Journal article
Quality of life in patients with pheochromocytoma and paraganglioma: influence of tumor type, genetics and surgical resection
- Abstract:
- Context: Pheochromocytomas and paragangliomas (PPGL) are rare endocrine tumors with high heritability. Carriers of pathogenic variants (PVs) in susceptibility genes face a lifelong risk of recurrence or metastatic disease. Quality of life (QoL) in patients with PPGL, a history of PPGL and PV carriers, remains insufficiently studied. Methods: We assessed patient-reported QoL in patients with PPGL before and after surgery and in carriers of susceptibility PVs for the development of PPGLs within the prospective ProsPheo study. QoL was evaluated using standardized questionnaires (SF-12, PHQ-D, and GAD-7). Results: A total of 202 participants were analyzed. SF-12 physical component summary scores (PCS) differed significantly across subgroups (P = .006), with the lowest PCS scores in patients with metastatic PPGL (40.3) and unresected head and neck paragangliomas (HNPGL) (40.0), compared with PV carriers after curative PPGL resection (50.2). Within metastatic disease, hormonally active tumors showed lower PCS scores than inactive tumors (36.9 vs 46.2; P = .03). Perceived physical health in carriers of a PV without history of a PPGL was significantly lower compared to the age-matched general population. Mental health was not significantly impaired across all subgroups. Clinically relevant anxiety was reported in 15.2% of PV carriers and 21.7% of patients with unresected HNPGLs, compared with about 5.9% in the general population. Conclusions: Patient-reported physical health was reduced in patients with metastatic PPGLs, unresected HNPGLs, and PV carriers without prior PPGL, whereas patients after curative PPGL resection reported QoL comparable to the general population, regardless of PV status, suggesting that annual follow-up has minimal impact on QoL.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 457.7KB, Terms of use)
-
- Publisher copy:
- 10.1093/ejendo/lvag003
Authors
+ Swiss Academy of Medical Sciences
More from this funder
- Funder identifier:
- https://ror.org/011cav305
- Publisher:
- Oxford University Press
- Journal:
- European journal of endocrinology More from this journal
- Volume:
- 194
- Issue:
- 2
- Pages:
- 80-90
- Publication date:
- 2026-01-12
- Acceptance date:
- 2025-12-29
- DOI:
- EISSN:
-
1479-683X
- ISSN:
-
0804-4643
- Language:
-
English
- Keywords:
- Pubs id:
-
2361011
- UUID:
-
uuid_3357a2c4-7f34-479b-beea-ca1689385222
- Local pid:
-
pubs:2361011
- Source identifiers:
-
3725520
- Deposit date:
-
2026-02-04
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2026
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record